get prepared for a squeeze that will make your eyes pop
But interesting. Per Fool: Since first hitting the markets in early 2014, Intra-Celluar Therapies (NASDAQ:ITCI), a drug developer focused on treating neuropsychiatric and neurologic disorders, has been on one heck of a profitable run. Shares have skyrocketed more than 246% since the company went public, crushing the returns of the iShares Nasdaq Biotechnology ETF.
Intra-Celluar Therapies' stock has been a rocket ship because of the exciting promise of its lead compound, ITI-007, which is currently being studied as a treatment for a range of mental illnesses such as depression, schizophrenia, bipolar depression, and more.
Intra-Celluar Therapies was a standout performer last year, rising more than 200% in response to the company's report of exciting phase 3 clinical data from a study of ITI-007's ability to treat schizophrenia. Patients who used ITI-007 demonstrated a statistically significant improvement in their "Positive and Negative Syndrome Scale" score (a measurement of the severity of schizophrenia) when compared to those who received placebo. That news took investors by surprise, and shares almost doubled in a single day on the news.
If ITI-007 turns out to be the real deal, this company's potential looks huge. Peak sales estimates are all over the map, but some analysts believe this drug could reach as much as $6 billion in worldwide sales if it wins approval for a number of indications. That's a huge number for a company with a market cap of about $1.5 billion as of this writing, especially when you consider that it holds $456.1 million in cash on its books at the end of March.
SO they think a $1.5 billion market cap is low for a company that could have potentially $6 billion in revenues from all indications. AVXL could have $20 billion in revenues from 273 for alz alone...then add in epilepsy, Rett, fragile X, parkinsons......maybe $30 billion in revenues all in. $7.5 billion market cap based on INtracellulars valuation would be over $200 per sh.
Keep wondering how these two together would work out given the research on Anatabien and alz also shows promiseper these articles:
Chronic Anatabine Treatment Reduces Alzheimer’s Disease (AD) – Like Pathology and Improves Socio-Behavioural Deficits in a Transgenic Mouse Model of AD
Anatabine Attenuates Tau Phosphorylation and Oligomerization in P301S Tau Transgenic Mice
Effects of anatabine at relevant human nicotinic receptor subtypes in vitro and on craving and C-reactive protein in heavy smokers
Amelioration of experimental autoimmune encephalomyelitis by anatabine
Anti-inflmmatory activity of anatabine via inhibition of STAT3 phosphorylation.
Anatabine ameliorates experimental autoimmune thryriditis
Anatabine lowers Alzheimer's Aβ production in vitro and in vivo.
I believe cutoff in mkt cap was $132 million for the 2000, so we are in . Therefore also in 3000
railroading Anatabloc as part of a political vendetta was one of the most loathsome things I have ever seen democrapts do
2% drop and you cry the sky is falling??? Grow a pair, my friend.
What happened in Britain was a GOOD THING. New World Order bankster occultists are losing their grip around the necks of the common man. Now elect Trump here in the USA.